These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2825993)

  • 21. Phase II study of mitomycin in small cell lung carcinoma.
    McHale MS; Einhorn LH
    Cancer Treat Rep; 1986 May; 70(5):675. PubMed ID: 3011261
    [No Abstract]   [Full Text] [Related]  

  • 22. Second-line chemotherapy and its evaluation in small cell lung cancer.
    Huisman C; Postmus PE; Giaccone G; Smit EF
    Cancer Treat Rev; 1999 Aug; 25(4):199-206. PubMed ID: 10448128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of vindesine in patients with non-small cell lung cancer.
    Fujita J; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Futami H; Sakurai M; Ishihara J; Takahashi H
    Jpn J Cancer Res; 1985 Sep; 76(9):902-5. PubMed ID: 2997097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
    Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
    Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II trial of streptozotocin for small cel anaplastic carcinoma of the lung.
    Kane RC; Bernath AM; Cashdollar MR
    Cancer Treat Rep; 1978 Mar; 62(3):477-8. PubMed ID: 206360
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.
    Ettinger DS; Finkelstein DM; Harper GR; Ruckdeschel JC; Chang AY; Camacho FJ; Marsh JC; Silber R; Wolter JM
    Cancer Treat Rep; 1985 Sep; 69(9):1033-4. PubMed ID: 3861248
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II trial of etoposide in previously treated small cell carcinoma of the lung.
    Antman K; Pomfret E; Karp G; Skarin A; Canellos G
    Cancer Treat Rep; 1984 Nov; 68(11):1413-4. PubMed ID: 6094004
    [No Abstract]   [Full Text] [Related]  

  • 29. [A phase II study of carboplatin in small cell lung cancer].
    Komatsu H; Furuse K; Nishikawa H; Minoda S; Saotome K; Nemoto E; Tani Y; Saito T; Ishiwata K; Tsutsumi M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2313-8. PubMed ID: 2841905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
    Remick SC; Neville AJ; Willson JK
    Cancer Treat Rep; 1987 Jun; 71(6):575-80. PubMed ID: 3034422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taxol in the treatment of lung cancer.
    Ettinger DS
    J Natl Cancer Inst Monogr; 1993; (15):177-9. PubMed ID: 7912523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
    Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R
    Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative evaluation of the combined chemotherapy and chemoradiation therapy of patients with a localized form of small-cell lung cancer].
    Ausekar BV; Bychkov MB; Mikhina ZP; Shchukina OP
    Vestn Akad Med Nauk SSSR; 1986; (5):12-5. PubMed ID: 3014775
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II study of procarbazine in small cell carcinoma of the lung.
    Pedersen AG; Sörenson S; Aabo K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):273-5. PubMed ID: 6275988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of teniposide in small cell carcinoma of the lung.
    Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
    Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial.
    Havsteen H; Sörenson S; Rørth M; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1981; 65(1-2):123-5. PubMed ID: 6261945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer.
    Socinski MA; Weissman C; Hart LL; Beck JT; Choksi JK; Hanson JP; Prager D; Monberg MJ; Ye Z; Obasaju CK
    J Clin Oncol; 2006 Oct; 24(30):4840-7. PubMed ID: 17050869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A phase II study of carboplatin in lung cancer. The Carboplatin Cooperative Study Group].
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2781-5. PubMed ID: 2843133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.